J. Vergniol

发表

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

V. de Lédinghen, P. Couzigou, B. le Bail, 2005, Gastroenterology.

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

V. de Lédinghen, P. Couzigou, B. le Bail, 2005, Gut.

The combination of a blood test and Fibroscan improves the non‐invasive diagnosis of liver fibrosis

V. de Lédinghen, F. Oberti, P. Calès, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

Julien Vergniol, V. Wong, V. de Lédinghen, 2010, Hepatology.

Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®.

Julien Vergniol, Michel Montaudon, François Laurent, 2014, Journal of hepatology.

Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy

Julien Vergniol, Christophe Aubé, V. de Lédinghen, 2016, Hepatology.

Assessment of Liver Disease Progression in Cystic Fibrosis Using Transient Elastography

V. de Lédinghen, E. Frison, R. Enaud, 2017, Journal of pediatric gastroenterology and nutrition.

A Single Test Combining Blood Markers and Elastography is More Accurate Than Other Fibrosis Tests in the Main Causes of Chronic Liver Diseases

V. de Lédinghen, B. le Bail, P. Calès, 2017, Journal of clinical gastroenterology.

Transient elastography (FibroScan).

V. de Lédinghen, J. Vergniol, 2008, Gastroenterologie clinique et biologique.

Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.

V. de Lédinghen, C. Camma', E. Bugianesi, 2019, The American journal of gastroenterology.

Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study.

T. de Baère, C. Lepage, G. Deplanque, 2020, Clinics and research in hepatology and gastroenterology.

Pravastatin combination with Sorafenib does not improve survival in advanced Hepatocellular Carcinoma.

O. Bouché, J. Seitz, J. Jouve, 2019, Journal of hepatology.

Optimizing hepatitis B vaccination in prison.

P. Trimoulet, J. Vergniol, M. Receveur, 2016, Medecine et maladies infectieuses.

Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).

V. de Lédinghen, Y. Ngo, M. Rudler, 2014, Journal of hepatology.

Transient elastography for the diagnosis of liver fibrosis

V. de Lédinghen, J. Vergniol, 2010, Expert review of medical devices.

989 NEW FIBROSCAN PROBE FOR OBESE PATIENTS. A PILOT STUDY OF FEASIBILITY AND PERFORMANCES IN PATIENTS WITH BMI ≥ 30 kg/m2

V. Rigalleau, L. Sandrin, C. Fournier, 2009 .

Screening for liver fibrosis by using FibroScan(®) and FibroTest in patients with diabetes.

V. de Lédinghen, H. Gin, V. Rigalleau, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: long-term follow-up of 196 patients (4535 patient-years).

V. de Lédinghen, P. Couzigou, H. Fleury, 2007, Journal of hepatology.

Efficacy of per-oral endoscopic myotomy for the treatment of non-achalasia esophageal motor disorders

S. Roman, T. Ponchon, F. Prat, 2020, Surgical Endoscopy.

Controlled attenuation parameter for the diagnosis of steatosis in non‐alcoholic fatty liver disease

V. Wong, H. Chan, B. le Bail, 2016, Journal of gastroenterology and hepatology.

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.

V. de Lédinghen, C. Cassinotto, J. Vergniol, 2014, Journal of hepatology.

Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD

V. de Lédinghen, H. Gin, V. Rigalleau, 2013, International journal of endocrinology.

Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values

V. Wong, V. de Lédinghen, F. Marra, 2017, Hepatology.

Impact of Obesity and ALT Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in NAFLD Patients

V. Wong, A. Chan, E. Bugianesi, 2020 .

Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

V. Wong, V. de Lédinghen, F. Marra, 2017, Alimentary pharmacology & therapeutics.

Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy

A. Amiot, G. Savoye, L. Peyrin-Biroulet, 2016, Inflammatory bowel diseases.

Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus

V. de Lédinghen, D. Thabut, N. Ganne-Carrié, 2020, World journal of hepatology.

Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results.

M. Rudler, D. Thabut, X. Causse, 2017, Journal of hepatology.

Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).

V. de Lédinghen, E. Schiff, Y. Ngo, 2014, Journal of hepatology.

Skin autofluorescence is high in patients with cirrhosis - further arguing for the implication of Advanced Glycation End products.

V. Rigalleau, J. Vergniol, V. Ledinghen, 2011, Journal of hepatology.

Rectovaginal fistula in Crohn’s disease treatment: a low long-term success rate and a high definitive stoma risk after a conservative surgical approach

J. Vergniol, B. Trilling, J. Faucheron, 2021, Techniques in Coloproctology.

Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C.

V. de Lédinghen, J. Vaillant, T. Poynard, 2012, Clinics and research in hepatology and gastroenterology.

Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard.

Julien Vergniol, Gilles Le Naour, G. le Naour, 2012, Journal of hepatology.

Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter.

V. Wong, V. de Lédinghen, A. Tuttolomondo, 2017, Journal of hepatology.

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.

Julien Vergniol, Paul Calès, V. de Lédinghen, 2016, Journal of hepatology.

Dynamic and Rapid Changes in Viral Quasispecies by Udps in Chronic Hepatitis C Patients Receiving Telaprevir-Based Therapy

V. de Lédinghen, H. Fleury, M. Kann, 2013, Antiviral therapy.

Non‐invasive tests for fibrosis and liver stiffness predict 5‐year survival of patients chronically infected with hepatitis B virus

T. Asselah, E. Zafrani, D. Guyader, 2013, Alimentary pharmacology & therapeutics.

Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver Biopsy

V. Paradis, P. Bedossa, J. Vergniol, 2017, Digestive Diseases and Sciences.

Epidemiological and phylogenetic evidence for patient‐to‐patient hepatitis C virus transmission during sclerotherapy of varicose veins

V. de Lédinghen, P. Couzigou, H. Fleury, 2005, Journal of medical virology.

Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver

V. de Lédinghen, P. Couzigou, P. Bioulac-Sage, 2010, European journal of gastroenterology & hepatology.

Feasibility of liver transient elastography with FibroScan® using a new probe for obese patients

V. de Lédinghen, V. Rigalleau, J. Vergniol, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Liver and spleen elastography using supersonic shear imaging for the non-invasive diagnosis of cirrhosis severity and oesophageal varices.

V. de Lédinghen, F. Laurent, M. Montaudon, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

Julien Vergniol, V. de Lédinghen, P. Couzigou, 2011, Gastroenterology.

Frequency of and Factors Associated With Sexual Dysfunction in Patients With Inflammatory Bowel Disease

J. Sabate, F. Zerbib, L. Peyrin-Biroulet, 2017, Journal of Crohn's & colitis.

Gastric variceal bleeding uncovering a rare association of CREST syndrome, primary biliary cirrhosis, nodular regenerative hyperplasia and pulmonary hypertension.

V. de Lédinghen, B. le Bail, J. Vergniol, 2010, European journal of gastroenterology & hepatology.

Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C

S. Bertrais, F. Oberti, P. Calès, 2014, Hepatology.

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

P. Couzigou, M. Ducreux, C. Borel, 2018, European journal of cancer.

Sexual quality of life is impaired in patients with chronic hepatitis C

J. Vergniol, J. Foucher, V. Ledinghen, 2016, International Journal of Impotence Research.

CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT Noninvasive Tests for Fibrosis and Liver Stiffness Predict 5-Year Outcomes of Patients With Chronic Hepatitis C

P. Couzigou, J. Vergniol, J. Foucher, 2011 .

P499 Sexual dysfunction is frequent among inflammatory bowel disease patients: results of a prospective study.

J. Sabate, F. Zerbib, L. Peyrin-Biroulet, 2017, Journal of Crohn's & Colitis.

MR relaxometry in chronic liver diseases: Comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity.

V. de Lédinghen, F. Laurent, H. Cochet, 2015, European journal of radiology.

Liver stiffness measurements for evaluation of central venous pressure in congenital heart diseases

V. de Lédinghen, T. Barnetche, J. Vergniol, 2015, Heart.

Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study.

V. de Lédinghen, P. Couzigou, L. Castéra, 2008, Gastroenterologie clinique et biologique.

Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease.

Julien Vergniol, V. de Lédinghen, B. le Bail, 2013, Radiology.

Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C

Gérard Forzy, Julien Vergniol, Laurent Castera, 2009, Hepatology.

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

N. Magné, B. Chauffert, F. Ducray, 2020, European Journal of Cancer.

Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child–Pugh B cirrhosis

C. Lepage, G. Deplanque, V. Bourcier, 2021, Hepatology International.

Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probe.

V. de Lédinghen, K. Leung, H. Chan, 2013, Annals of hepatology.

Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease

V. Wong, H. Chan, A. Chan, 2012, The American Journal of Gastroenterology.

Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®.

V. Wong, V. de Lédinghen, H. Chan, 2012, Journal of hepatology.

Paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome: therapeutic challenge with bone marrow transplantation, transjugular intrahepatic portosystemic shunt, and vena cava stent.

V. de Lédinghen, P. Couzigou, J. Vergniol, 2005, European journal of gastroenterology & hepatology.

Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

J. Vergniol, J. Foucher, V. Ledinghen, 2012, Liver international : official journal of the International Association for the Study of the Liver.

HCV: Fibrosis Progression

J. Vergniol, V. Ledinghen, 2014, Current Hepatology Reports.

FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate.

V. de Lédinghen, D. Thabut, T. Poynard, 2011, Clinics and research in hepatology and gastroenterology.

Non-invasive evaluation of liver fibrosis using FibroScan in long-term sustained-virological responder patients after HCV treatment.

V. de Lédinghen, P. Couzigou, L. Castéra, 2008, Gastroenterologie clinique et biologique.

2305 Randomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part

T. Baère, C. Lepage, V. Boige, 2015 .

Changes of non‐invasive markers and FibroScan values during HCV treatment

V. de Lédinghen, P. Couzigou, L. Castéra, 2009, Journal of viral hepatitis.

EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice

Ivan Bricault, Julien Vergniol, Vincent Leroy, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Commentary: prognostication of chronic hepatitis B – are Fibrotest and Fibroscan the final answers? Authors' reply

J. Vergniol, V. Ledinghen, 2013, Alimentary pharmacology & therapeutics.

231 PROGNOSTIC VALUE OF TRANSIENT ELASTOGRAPHY AND NON-INVASIVE MARKERS OF FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASE. A PROSPECTIVE ANALYSIS OF 4,935 PERSON-YEARS

P. Couzigou, J. Font, J. Vergniol, 2009 .

Performances of Elasto-FibroTest ® , a combination between FibroTest ® and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C

J. Vaillant, T. Poynard, V. Ratziu, 2012 .

Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failures

K. Reddy, P. Kamath, S. Biggins, 2014, Hepatology.

G. le Naour, V. de Lédinghen, J. Vaillant, 2012, Journal of hepatology.